- Home
- TXMD vs FLGC Comparison
TXMD vs FLGC Comparison
Compare TXMD & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- FLGC
- Stock Information
- Founded
- TXMD 2008
- FLGC 2019
- Country
- TXMD United States
- FLGC United States
- Employees
- TXMD N/A
- FLGC N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- TXMD Health Care
- FLGC Health Care
- Exchange
- TXMD Nasdaq
- FLGC Nasdaq
- Market Cap
- TXMD 12.8M
- FLGC 15.9M
- IPO Year
- TXMD N/A
- FLGC 2021
- Fundamental
- Price
- TXMD $1.14
- FLGC $0.62
- Analyst Decision
- TXMD
- FLGC Buy
- Analyst Count
- TXMD 0
- FLGC 2
- Target Price
- TXMD N/A
- FLGC $4.00
- AVG Volume (30 Days)
- TXMD 70.8K
- FLGC 111.0K
- Earning Date
- TXMD 08-11-2025
- FLGC 08-11-2025
- Dividend Yield
- TXMD N/A
- FLGC N/A
- EPS Growth
- TXMD N/A
- FLGC N/A
- EPS
- TXMD N/A
- FLGC N/A
- Revenue
- TXMD $1,841,000.00
- FLGC $53,260,000.00
- Revenue This Year
- TXMD $427.09
- FLGC N/A
- Revenue Next Year
- TXMD N/A
- FLGC N/A
- P/E Ratio
- TXMD N/A
- FLGC N/A
- Revenue Growth
- TXMD 53.55
- FLGC N/A
- 52 Week Low
- TXMD $0.70
- FLGC $0.42
- 52 Week High
- TXMD $2.44
- FLGC $2.11
- Technical
- Relative Strength Index (RSI)
- TXMD 47.25
- FLGC 42.89
- Support Level
- TXMD $1.11
- FLGC $0.62
- Resistance Level
- TXMD $1.22
- FLGC $0.72
- Average True Range (ATR)
- TXMD 0.09
- FLGC 0.06
- MACD
- TXMD 0.00
- FLGC -0.01
- Stochastic Oscillator
- TXMD 42.31
- FLGC 14.79
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.